Skip to content
Screener

Medifast MED Q1 2026 earnings

Reported May 4, 2026 · After market close

Revenue$76.0MBeat by $6.8M
EPS-$0.19Beat by $0.36
Revenue estimate$69.2M
EPS estimate-$0.55

Next report

Nov 9, 2026 (in 2 months)
Revenue estimate$71.3M
EPS estimate-$0.35

Financials

Q1 2026

Income statement

See full
Revenue$76.0M-34.3%
Gross profit$51.8M-38.6%
Operating income-$3.3M-161%
Net income-$2.1M-175%
EPS (diluted)-$0.19-171%

Balance sheet

See full
Cash & equivalents$71.5M-22.0%
Total debt$16.1M+10.2%
Total equity$197.7M-6.3%
Total assets$252.0M-10.0%

Cash flow

See full
Operating cash flow$260.0K-92.4%
CapEx$1.1M-28.0%
Free cash flow-$836.0K-144%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$112M-24.0%
Enterprise value$56.57M-19.6%
P/S0.3×+0.1×

Profitability

See full
Gross margin70.1%-3.8pp
Operating margin-4.7%-7.0pp
Net margin-5.8%-8.1pp

Returns & leverage

See full
Return on equity-9.8%-20.1pp
Debt / equity0.1×0.0×
Current ratio4.8×+1.3×

Segments

By segment

See full
Optavia Segment$76.0M-34.3%

FAQ

When did Medifast report Q1 2026 earnings?
Medifast (MED) reported Q1 2026 earnings on May 4, 2026 after market close.
What were Medifast's Q1 2026 revenue and EPS?
Medifast reported revenue of $76.0M and eps of $-0.19 for Q1 2026.
Did Medifast beat estimates in Q1 2026?
Revenue beat the consensus estimate of $69.2M by $6.8M. EPS beat the consensus estimate of $-0.55 by $0.36.
How did Medifast's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 34.3% from $115.7M a year earlier and eps declined 72.7% from $-0.11.
Where can I find Medifast's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-029812) and the 10-Q periodic report (0001628280-26-029898) directly on SEC EDGAR. The filing index links above go to sec.gov.